SymBio Pharmaceuticals
SymBio Pharmaceuticals aims to develop drugs for patients overlooked by the industry, ensuring vital treatments reach those in need.
Launch date
Employees
Market cap
CAD116m
Enterprise valuation
CAD49m (Public information from Sep 2024)
Share price
JPY252 4582.T
Durham North Carolina (HQ)
Authorizing premium user...